Benralizumab in the treatment of severe asthma: design, development and potential place in therapy

by Pelaia C, Vatrella A, Bruni A, Terracciano R, Pelaia G
Published 2018-03-01

Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab

by Pelaia C, Vatrella A, Busceti MT, Gallelli L, Terracciano R, Savino R, Pelaia G
Published 2017-10-01

Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD

by Pelaia G, Vatrella A, Busceti MT, Gallelli L, Calabrese C, Terracciano R, Lombardo N, Maselli R
Published 2015-10-01

Role of biologics in severe eosinophilic asthma – focus on reslizumab

by Pelaia G, Vatrella A, Busceti MT, Gallelli L, Preianò M, Lombardo N, Terracciano R, Maselli R
Published 2016-07-01